The purpose of this study is to find out more about an investigational drug, ISIS 304801. ISIS 304801 is being developed to see if it can help people with hypertriglyceridemia (triglycerides greater than 500). This study will compare ISIS 304801 with a placebo to see if using ISIS 304801 is better than using a placebo.

Participation will be less than a year and involve up to 12 study visits. The visits are in person. Some visits may be done by a healthcare nurse in your home, for your convenience.

A travel service will be made available to you and a companion if needed, at no cost to you.

Site: Baylor College of Medicine
Study Doctor: Christie Ballantyne, M.D.
Study Contact: Sharon Goss (713) 798-8800 or


Sharon Goss sgoss@bcm.eduPhone 1: (713) 798-8800
IRB: h-37273




Sep 14, 2015